Astatine-211 based PSMA-inhibitors for targeted alpha-therapy of prostate cancer

被引：0
|
作者：
Poulie, Christian [1 ]
El Fakiri, Mohamed [2 ]
Ayada, Nawal [2 ]
Gamzov, Teodor [1 ]
Muller, Marius [1 ]
Jensen, Holger [3 ]
Lindegren, Sture [4 ]
Jensen, Andreas [1 ,5 ]
Kjaer, Andreas
Eder, Ann-Christin [2 ]
Eder, Matthias [6 ]
Herth, Matthias [1 ]
机构：
[1] Univ Copenhagen, Copenhagen, Denmark
[2] German Canc Res Ctr, Heidelberg, Germany
[3] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[4] Univ Gothenburg, Gothenburg, Sweden
[5] Tech Univ Denmark, Lyngby, Denmark
[6] Univ Med Ctr, Freiburg, Germany
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-017
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [31] Advances in PSMA-targeted therapy for prostate cancer
    Fujin Wang
    Zhifeng Li
    Xiaoqian Feng
    Dazhuang Yang
    Mei Lin
    Prostate Cancer and Prostatic Diseases, 2022, 25 : 11 - 26
  • [32] PSMA-targeted radioligand therapy in prostate cancer
    Heck, M. M.
    Retz, M.
    Tauber, R.
    Knorr, K.
    Kratochwil, C.
    Eiber, M.
    UROLOGE, 2017, 56 (01): : 32 - 39
  • [33] Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer
    Vaidyanathan, Ganesan
    Mease, Ronnie C.
    Minn, Il
    Choi, Jaeyeon
    Chen, Ying
    Shallal, Hassan
    Kang, Choong Mo
    McDougald, Darryl
    Kumar, Vivek
    Pomper, Martin G.
    Zalutsky, Michael R.
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 94-95 : 67 - 80
  • [34] Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease
    Gouard, Sebastien
    Maurel, Catherine
    Marionneau-Lambot, Severine
    Dansette, Delphine
    Bailly, Clement
    Guerard, Francois
    Chouin, Nicolas
    Haddad, Ferid
    Alliot, Cyril
    Gaschet, Joelle
    Eychenne, Romain
    Kraeber-Bodere, Francoise
    Cherel, Michel
    CANCERS, 2020, 12 (09) : 1 - 18
  • [35] The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer
    Michael J. Willhauck
    Bibi-Rana Sharif Samani
    Ingo Wolf
    Reingard Senekowitsch-Schmidtke
    Hans-Jürgen Stark
    Geerd J. Meyer
    Wolfram H. Knapp
    Burkhard Göke
    John C. Morris
    Christine Spitzweg
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35
  • [36] Correction to: Global experience with PSMA‑based alpha therapy in prostate cancer
    Mike M. Sathekge
    Frank Bruchertseifer
    Mariza Vorster
    Alfred Morgenstern
    Ismaheel O. Lawal
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 49 : 73 - 73
  • [37] Global experience with PSMA-based alpha therapy in prostate cancer
    Mike M. Sathekge
    Frank Bruchertseifer
    Mariza Vorster
    Alfred Morgenstern
    Ismaheel O. Lawal
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 49 : 30 - 46
  • [38] The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer
    Willhauck, Michael J.
    Samani, Bibi-Rana Sharif
    Wolf, Ingo
    Senekowitsch-Schmidtke, Reingard
    Stark, Hans-Juergen
    Meyer, Geerd J.
    Knapp, Wolfram H.
    Goeke, Burkhard
    Morris, John C.
    Spitzweg, Christine
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (07) : 1272 - 1281
  • [39] Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
    Hammer, Stefanie
    Hagemann, Urs B.
    Zitzmann-Kolbe, Sabine
    Larsen, Aasmund
    Ellingsen, Christine
    Geraudie, Solene
    Grant, Derek
    Indrevoll, Baard
    Smeets, Roger
    von Ahsen, Oliver
    Kristian, Alexander
    Lejeune, Pascale
    Hennekes, Hartwig
    Karlsson, Jenny
    Bjerke, Roger M.
    Ryan, Olav B.
    Cuthbertson, Alan S.
    Mumberg, Dominik
    CLINICAL CANCER RESEARCH, 2020, 26 (08) : 1985 - 1996
  • [40] Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors
    Back, Tom A.
    Jennbacken, Karin
    Thulin, Malin Hagberg
    Lindegren, Sture
    Jensen, Holger
    Olafsen, Tove
    Yazaki, Paul J.
    Palm, Stig
    Albertsson, Per
    Damber, Jan-Erik
    Wu, Anna M.
    Welen, Karin
    EJNMMI RESEARCH, 2020, 10 (01)
12345